Answers are grounded in this paper and cite their sources.
These findings suggest an underlying dysregulation of hepatic GCK expression during frank diabetes, which has implications for the therapeutic use of glucokinase activators in this population.
No takes yet. Share an insight, caveat, or question.
Haeusler et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: